Company news

KalVista Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference

May 26, 2021

KalVista Pharmaceuticals Expands Senior Leadership Team with Appointment of Paul K. Audhya, MD, MBA as Chief Medical Officer

May 2, 2021

KalVista Pharmaceuticals Provides Regulatory Update for Phase 2 Clinical Trial of KVD824

April 19, 2021

KalVista Pharmaceuticals Appoints Nancy Stuart to Board of Directors

March 18, 2021

KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

February 15, 2021

KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock

February 9, 2021

KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock

February 8, 2021

KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise

October 14, 2020

KalVista Pharmaceuticals Provides Operational and Financial Update

April 6, 2020

KalVista Pharmaceuticals Reports Fiscal Third Quarter Results

March 9, 2020

KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs

February 9, 2020

KalVista Pharmaceuticals Reports Phase 2 Clinical Trial Results in Patients with Diabetic Macular Edema

December 8, 2019

KalVista Pharmaceuticals Reports Fiscal Second Quarter Results

December 2, 2019

← Newer news releases

Calls

Decks

The 5 newest of 17 decks. Every deck is listed under its year.